Comparison of population characteristics in real-world clinical oncology databases in the US: Flatiron Health, SEER, and NPCR
Background and Objective The Surveillance, Epidemiology, and End Results Program (SEER)
program and the National Program of Cancer Registries (NPCR), are authoritative …
program and the National Program of Cancer Registries (NPCR), are authoritative …
Affordable Care Act (ACA) Medicaid expansion impact on racial disparities in time to cancer treatment.
LBA1 Background: Racial disparities in cancer outcomes remain a societal challenge. The
ACA sought to improve equity in healthcare access and outcomes by permitting states to …
ACA sought to improve equity in healthcare access and outcomes by permitting states to …
Effectiveness of first-line immune checkpoint blockade versus carboplatin-based chemotherapy for metastatic urothelial cancer
… Meropol, Blythe JS Adamson, and Aaron Cohen report employment at Flatiron Health, Inc.,
which is an independent subsidiary of the Roche Group. John Christodouleas reports part-…
which is an independent subsidiary of the Roche Group. John Christodouleas reports part-…
Trends in checkpoint inhibitor therapy for advanced urothelial cell carcinoma at the end of life: insights from real‐world practice
Several immune checkpoint inhibitor therapies (CPIs) have been approved to treat metastatic
urothelial cell carcinoma (mUC). Because of the favorable toxicity profile of CPI compared …
urothelial cell carcinoma (mUC). Because of the favorable toxicity profile of CPI compared …
ACA Medicaid expansion association with racial disparity reductions in timely cancer treatment.
OBJECTIVES: Racial disparities in cancer care and outcomes remain a societal challenge.
Medicaid expansion through the Affordable Care Act was intended to improve health care …
Medicaid expansion through the Affordable Care Act was intended to improve health care …
Association between FDA label restriction and immunotherapy and chemotherapy use in bladder cancer
Methods| This interrupted time-series analysis included patients diagnosed as having advanced
bladder cancer between January 1, 2016, and January 31, 2019, who were treated with …
bladder cancer between January 1, 2016, and January 31, 2019, who were treated with …
Differential frequency in imaging‐based outcome measurement: Bias in real‐world oncology comparative‐effectiveness studies
Background Comparative‐effectiveness studies using real‐world data (RWD) can be
susceptible to surveillance bias. In solid tumor oncology studies, analyses of endpoints such as …
susceptible to surveillance bias. In solid tumor oncology studies, analyses of endpoints such as …
[HTML][HTML] The potential cost-effectiveness of pre-exposure prophylaxis combined with HIV vaccines in the United States
… ; Blythe JS Adamson developed the mathematical model and performed the analysis; Blythe
JS Adamson… Carlson interpreted the results; Blythe JS Adamson and Josh J. Carlson drafted …
JS Adamson… Carlson interpreted the results; Blythe JS Adamson and Josh J. Carlson drafted …
[HTML][HTML] Projected effectiveness and added value of HIV vaccination campaigns in South Africa: A modeling study
S de Montigny, BJS Adamson, BR Mâsse… - Scientific Reports, 2018 - nature.com
Promising multi-dose HIV vaccine regimens are being tested in trials in South Africa. We
estimated the potential epidemiological and economic impact of HIV vaccine campaigns …
estimated the potential epidemiological and economic impact of HIV vaccine campaigns …
First-line immune checkpoint inhibitor use in cisplatin-eligible patients with advanced urothelial carcinoma: A secular trend analysis
RB Parikh, EK Feld, MD Galsky, BJS Adamson… - Future …, 2020 - Future Medicine
Aim: Standard first-line treatment of advanced urothelial cell carcinoma involves cisplatin-based
chemotherapy, with carboplatin or immune checkpoint inhibitor therapy (ICI) reserved …
chemotherapy, with carboplatin or immune checkpoint inhibitor therapy (ICI) reserved …